InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today released the following statement. Recently, H.R. 5371, the ‘Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and…
Rio Silver Inc. (the ‘Company’ or ‘Rio Silver’) (TSX.V: RYO,OTC:RYOOF) (OTC: RYOOF) announces that, following regulatory approval, the closing…
The Bank of Canada Governing Council met on Wednesday (December 10) for the final rate-setting meeting of 2025 and…
Contango ORE (NYSEAMERICAN:CTGO) and Dolly Varden Silver (TSXV:DV) have agreed to merge in an all-stock deal that would create…
Japan’s largest copper smelter has secured a rare reprieve in one of the tightest processing-fee environments the industry has…
(TheNewswire) Vancouver, Canada, December 12, 2025 TheNewswire – Spartan Metals Corp. (‘ Spartan ‘ or the ‘ Company ‘)…
Bold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce the closing of a non-brokered private placement…